Tech Company Financing Transactions

LabGenius Funding Round

M Ventures, Atomico and Kindred Capital invested in a $44 million Series B capital raise for LabGenius. This venture round was announced on 5/21/2024.

Transaction Overview

Company Name
Announced On
5/21/2024
Transaction Type
Venture Equity
Amount
$44,000,000
Round
Series B
Proceeds Purpose
The company intends to use the funds to further develop its proprietary machine learning (ML)-driven drug discovery platform, which enables the rapid identification of biotherapeutics, and to progress a wholly-owned pipeline of multispecific antibodies for the treatment of solid tumours towards the clinic.

Company Information

Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
G04 Cocoa Studios The Biscuit Factory 100 Drummond Road
London, SE16 4DG
UK
Email Address
Overview
The next wave of major scientific breakthroughs will be unlocked by technology platforms capable of combining the very best of human ingenuity and machine intelligence. Our mission is to accelerate the discovery of next-generation therapeutic antibodies that have been designed for maximum potential. To do this, we're pioneering the development of a smart robotic platform (EVA�) that's capable of designing, conducting and -- critically -- learning from its own experiments.
Profile
LabGenius LinkedIn Company Profile
Social Media
LabGenius Company Twitter Account
Company News
LabGenius News
Facebook
LabGenius on Facebook
YouTube
LabGenius on YouTube

Management Team

Title
Name
Email & Social
Chairman
Edwin Moses
  Edwin Moses LinkedIn Profile  Edwin Moses Twitter Account  Edwin Moses News  Edwin Moses on Facebook
Chief Executive Officer
James Field
  James Field LinkedIn Profile  James Field Twitter Account  James Field News  James Field on Facebook
Chief Scientific Officer
Gino Van Heeke
  Gino Van Heeke LinkedIn Profile  Gino Van Heeke Twitter Account  Gino Van Heeke News  Gino Van Heeke on Facebook
Chief Technical Officer
Leonard Wossnig
  Leonard Wossnig LinkedIn Profile  Leonard Wossnig Twitter Account  Leonard Wossnig News  Leonard Wossnig on Facebook
VP - Finance
Edward de Moraville
  Edward de Moraville LinkedIn Profile  Edward de Moraville Twitter Account  Edward de Moraville News  Edward de Moraville on Facebook
VP - Human Resources
Caroline Thomson
  Caroline Thomson LinkedIn Profile  Caroline Thomson Twitter Account  Caroline Thomson News  Caroline Thomson on Facebook
VP - Marketing
Lucy Shaw
  Lucy Shaw LinkedIn Profile  Lucy Shaw Twitter Account  Lucy Shaw News  Lucy Shaw on Facebook


 

 

Browse more venture capital transactions:

Prev: 5/21/2024: Reactive Technologies venture capital transaction
Next: 5/21/2024: Tuesday Health venture capital transaction

 

Share this article

 


About Our Venture Capital Transactions Database

We report on every notable VC transaction. VC transactions reported here come from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary